ID NOW is one of the most widely-available molecular point-of-care testing technologies in use in the U.S. Since its introduction in 2014, it has been used in physicians’ offices and urgent care centres to rapidly detect COVID-19 infection.
ID NOW is approved by the Department of Health and care – UK.
The test uses isothermal technology, proprietary enzymes and constant temperature control to achieve the fastest available RNA amplification. This proven molecular system greatly reduces the time for results, allowing healthcare providers to make patient care decisions sooner.
To conduct a test, a swab of the nose is taken. Then the swab is placed into an acidic liquid solution heated to 59⁰C that cracks open the envelope of the SARS-CoV-2 virus, exposing its viral RNA. Then the small device, about the size of a toaster and weighing only 6.6 pounds, amplifies the RNA hundreds of millions of times to make the virus detectable — returning test results in 13 minutes or less.
ID NOW gives fast results; it is reliable and have high accuracy results we use ID NOW to test patients before surgery.